Clinical Trials Browser

Glioblastoma, Recurrence

NCT05432375 2025-12-10

Study of Tinostamustine for Adjuvant Treatment of Glioblastoma

Phase EARLY_PHASE1 Completed

10 enrolled

CNS

Glioblastoma

NCT03452930 2025-06-04

Tinostamustine With or Without Radiation Therapy in Treating Patients With Newly Diagnosed MGMT-Unmethylated Glioblastoma

Phase 1 Completed

5 enrolled

CNSSarcoma

Glioblastoma, Gliosarcoma

NCT03345485 2024-10-21

EDO-S101

Phase 1/2 Completed

71 enrolled 39 charts

BreastGastrointestinalGynecologicSarcomaThoracic

Breast Neoplasms, Fallopian Tube Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Recurrence, Sarcoma, Endometrial Neoplasms, Gastrointestinal Stromal Tumors, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT02576496 2024-07-25

Study of Tinostamustine, First-in-Class Alkylating HDACi Fusion Molecule, in Relapsed/Refractory Hematologic Malignancies

Phase 1 Completed

106 enrolled

DermatologicLymphoidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Multiple Myeloma, Lymphoma, T-Cell, Cutaneous, Hematologic Neoplasms

NCT03903458 2019-04-08

ENIgMA

Phase 1 Unknown

21 enrolled

Dermatologic

Melanoma

Clinical Trials

GBM AGILE

Study of Tinostamustine for Adjuvant Treatment of Glioblastoma

Tinostamustine With or Without Radiation Therapy in Treating Patients With Newly Diagnosed MGMT-Unmethylated Glioblastoma

EDO-S101

Study of Tinostamustine, First-in-Class Alkylating HDACi Fusion Molecule, in Relapsed/Refractory Hematologic Malignancies

ENIgMA